
|Articles|March 15, 2003
FDA seeks innovation, shorter review process
Washington, DC-The FDA is proposing a set of guidelines geared toward improving the development and availability of new drugs and medical devices.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
2
Reasoning prompts sharpen multimodal AI on bilingual ophthalmology exam questions
3
Beyond the Walls: Leading with love, loyalty, and a team first philosophy with Vance Thompson, MD
4
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
5





















